Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Bullous SLE: a phenotypically distinctive but immunologically heterogeneous bullous disorder.

The Journal of investigative dermatology - 1 Jan 1993

Gammon W R, Briggaman R A

Abstract excerpt

Bullous systemic lupus erythematosus (SLE) is a rare blistering disease with a distinctive combination of clinical, histologic and immunopathologic features that together constitute a unique bullous disease phenotype. There appear to be at least two immunologically distinct subtypes of bullous SLE characterized by the presence or absence of circulating and/or tissue-bound basement membrane zone autoantibodies...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoantibodies
Share to Collagen
Share to Diagnosis, Differential

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lupus Erythematosus, Systemic

Share to Phenotype

Source

Identifiers

PMID: 8423389
DOI: 10.1111/1523-1747.ep12355210

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Bullous SLE: a phenotypically distinctive but immunologically heterogeneous bullous disorder.PMID 8423389Read ↗

Epidermolysis bullosa acquisita: a disease of autoimmunity to type VII collagen.Semantic proximity Read ↗

Type VII Collagen Disorders Simplified.Semantic proximity Read ↗

Autoantibodies to type VII collagen have heterogeneous subclass and light chain compositions and their complement-activating capacities do not correlate with the inflammatory clinical phenotype.Semantic proximity Read ↗

The role of antibody class and target on subepidermal blistering disease phenotype and management.Semantic proximity Read ↗

Hermann Pinkus Memorial Lecture--1992. Autoimmunity to collagen VII: Autoantibody-mediated pathomechanisms regulate clinical-pathological phenotypes of acquired epidermolysis bullosa and bullous SLE.Semantic proximity Read ↗

Induction of complement-fixing autoantibodies against type VII collagen results in subepidermal blistering in mice.Semantic proximity Read ↗

Hemidesmosomal variants of epidermolysis bullosa. Mutations in the alpha6beta4 integrin and the 180-kD bullous pemphigoid antigen/type XVII collagen genes.Semantic proximity Read ↗

IgM-type epidermolysis bullosa acquisita.Semantic proximity Read ↗

Update on antiglomerular basement membrane disease.Semantic proximity Read ↗

HLA genotype, clinical and immunofluorescence findings of 30 patients with type VII collagen antibody positive subepidermal bullous disease.Semantic proximity Read ↗

Bullous systemic lupus erythematosus--a case report and review.Semantic proximity Read ↗

Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.